AXGN EBITDA | Axogen, Inc.

Axogen, Inc. (AXGN) EBITDA

2026-06-30: Basis Reported; EBITDA -$549.00K*; Operating income -$2.16M; Depreciation and amortization $1.61M*.
2026-03-31: Basis Reported; EBITDA -$1.23M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$8.14M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $3.55M*; Operating income $1.91M; Depreciation and amortization $1.64M*.

Complete source-backed ebitda history.

Available history: 2011-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$549.00K*	-$2.16M	$1.61M*	(m)	(m)	$893.00K*	$7.22M*	$19.06M	$8.59M	(m)	$0.00
2026-03-31	Reported	-$1.23M	(m)	(m)	(m)	-2.00%	$2.79M	$1.56M	$15.27M	$7.52M	(m)	$0.00
2025-12-31	Reported	-$8.14M	(m)	(m)	(m)	-13.59%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$3.55M*	$1.91M	$1.64M*	(m)	(m)	$1.52M*	$3.22M*	$14.09M	$7.57M	(m)	$0.00
2025-06-30	Reported	$3.33M*	$1.67M	$1.66M*	(m)	(m)	$722.00K*	$7.73M*	$14.64M	$6.85M	(m)	$0.00
2025-03-31	Reported	$67,000.00	(m)	(m)	(m)	0.14%	$256.00K	-$13.18M	$13.63M	$6.09M	(m)	$0.00
2024-12-31	Reported	$3.65M	(m)	(m)	(m)	7.39%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$1.34M*	-$316.00K	$1.65M*	(m)	(m)	$597.00K*	$3.90M*	$12.21M	$7.00M	(m)	$0.00
2024-06-30	Reported	$1.23M*	-$428.00K	$1.66M*	(m)	(m)	$910.00K*	$4.17M*	$12.57M	$6.66M	(m)	$0.00
2024-03-31	Reported	-$3.04M	(m)	(m)	(m)	-7.35%	$924.00K	-$12.27M	$8.76M	$7.41M	(m)	$0.00
2023-12-31	Reported	-$1.64M	(m)	(m)	(m)	-3.81%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$2.87M*	-$4.03M	$1.15M*	(m)	(m)	$3.69M*	$1.63M*	$9.57M	$6.69M	(m)	(m)
2023-06-30	Reported	-$6.11M*	-$6.90M	$797.00K*	(m)	(m)	$4.42M*	$292.00K*	$8.50M	$7.14M	(m)	(m)
2023-03-31	Reported	-$6.63M	(m)	(m)	(m)	-18.09%	$4.30M	-$7.42M	$8.17M	$6.33M	(m)	(m)
2022-12-31	Reported	-$4.96M	(m)	(m)	(m)	-13.72%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$4.09M*	-$4.86M	$764.00K*	(m)	(m)	$4.37M*	-$689.00K*	$6.18M	$7.05M	(m)	(m)
2022-06-30	Reported	-$7.21M*	-$7.92M	$714.00K*	(m)	(m)	$4.05M*	-$5.69M*	$6.28M	$7.02M	(m)	(m)
2022-03-31	Reported	-$10.62M	(m)	(m)	(m)	-34.24%	$5.04M	-$11.05M	$5.55M	$6.28M	(m)	(m)
2021-12-31	Reported	-$4.67M	(m)	(m)	(m)	-14.80%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$6.04M*	-$6.69M	$654.00K*	(m)	(m)	$9.72M*	-$376.00K*	$5.24M	$6.40M	(m)	(m)
2021-06-30	Reported	-$6.52M*	-$7.15M	$633.00K*	(m)	(m)	$7.83M*	-$695.00K*	$7.09M	$5.72M	(m)	(m)
2021-03-31	Reported	-$5.45M	(m)	(m)	(m)	-17.55%	$3.10M	-$10.82M	$5.17M	$5.75M	(m)	(m)
2020-09-30	Reported	(m)	-$1.04M	(m)	(m)	(m)	$5.72M*	$2.62M*	$5.70M	$4.23M	(m)	(m)
2020-06-30	Reported	(m)	-$8.25M	(m)	(m)	(m)	$8.16M*	-$7.03M*	$5.61M	$4.07M	(m)	(m)
2020-03-31	Reported	(m)	-$8.51M	(m)	(m)	(m)	$5.02M	-$8.05M	$4.82M	$4.61M	(m)	(m)
2019-09-30	Reported	(m)	-$6.11M	(m)	(m)	(m)	$1.99M*	-$1.86M*	$4.51M	$4.18M	(m)	(m)
2019-06-30	Reported	(m)	-$7.67M	(m)	(m)	(m)	$1.21M*	-$5.81M*	$4.24M	$4.28M	(m)	(m)
2019-03-31	Reported	(m)	-$10.20M	(m)	(m)	(m)	$478.00K	-$8.87M	$3.71M	$4.14M	(m)	(m)
2018-09-30	Reported	(m)	-$4.83M	(m)	(m)	(m)	$5.40M*	-$2.97M*	$3.46M	$3.31M	(m)	(m)
2018-06-30	Reported	(m)	-$4.82M	(m)	(m)	(m)	$294.00K*	-$4.08M*	$3.11M	$2.60M	(m)	(m)
2018-03-31	Reported	(m)	-$4.99M	(m)	(m)	(m)	$360.00K	-$5.84M	$2.71M	$2.06M	(m)	(m)
2017-09-30	Reported	(m)	-$1.50M	(m)	(m)	(m)	$249.55K*	-$2.16M*	(m)	$1.80M	(m)	(m)
2017-06-30	Reported	(m)	-$1.45M	(m)	(m)	(m)	$268.50K*	-$2.07M*	(m)	$1.52M	(m)	(m)
2017-03-31	Reported	(m)	-$3.20M	(m)	(m)	(m)	$98.39K	-$3.95M	(m)	$1.41M	(m)	(m)
2016-09-30	Reported	(m)	-$1.18M	(m)	(m)	(m)	$156.06K*	(m)	(m)	$1.12M	(m)	(m)
2016-06-30	Reported	(m)	-$1.61M	(m)	(m)	(m)	$53.98K*	(m)	(m)	$936.82K	(m)	(m)
2016-03-31	Reported	-$2.54M	(m)	(m)	(m)	-31.36%	$402.93K	(m)	(m)	$978.34K	(m)	(m)
2015-09-30	Reported	-$1.86M*	-$1.92M	$54.43K*	(m)	(m)	$220.60K*	(m)	(m)	$936.01K	(m)	(m)
2015-06-30	Reported	-$2.11M*	-$2.15M	$45.71K*	(m)	(m)	$126.20K*	(m)	(m)	$736.40K	(m)	(m)
2015-03-31	Reported	-$2.5M	(m)	(m)	(m)	-50.53%	$6.29K	(m)	(m)	$671.04K	(m)	(m)
2014-12-31	Reported	-$2.67M	(m)	(m)	(m)	-55.63%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$1.76M*	-$1.80M	$43.50K*	(m)	(m)	$59.40K*	(m)	(m)	$681.23K	(m)	(m)
2014-06-30	Reported	-$2.26M*	-$2.30M	$33.94K*	(m)	(m)	$87.99K*	(m)	(m)	$555.76K	(m)	(m)
2014-03-31	Reported	-$2.96M	(m)	(m)	(m)	-94.23%	$195.48K	(m)	(m)	$812.62K	(m)	(m)
2013-12-31	Reported	-$2.78M	(m)	(m)	(m)	-93.11%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$2.26M*	-$2.28M	$18.06K*	(m)	(m)	$21.25K*	-$2.90M*	(m)	$593.64K	(m)	$0.00
2013-06-30	Reported	-$2.17M*	-$2.19M	$19.67K*	(m)	(m)	$19.31K*	-$2.51M*	(m)	$498.32K	(m)	(m)
2013-03-31	Reported	-$2.3M	(m)	(m)	(m)	-107.35%	$26.01K	-$2.65M	(m)	$406.94K	(m)	(m)
2012-12-31	Reported	-$2.19M	(m)	(m)	(m)	-107.06%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$2.00M*	-$2.04M	$44.02K*	(m)	(m)	$6.39K*	-$1.82M*	(m)	$390.39K	(m)	$0.00
2012-06-30	Reported	-$1.54M*	-$1.59M	$46.18K*	(m)	(m)	$1.73K*	-$985.99K*	(m)	$367.36K	(m)	-$736.43K
2012-03-31	Reported	-$1.89M	(m)	(m)	(m)	-114.03%	$29.31K	-$2.48M	(m)	$296.13K	(m)	(m)
2011-12-31	Reported	-$1.93M	(m)	(m)	(m)	-141.78%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$2.56M*	-$2.63M	$67.76K*	(m)	(m)	(m)	-$2.43M*	(m)	$229.71K	(m)	(m)
2011-06-30	Reported	(m)	-$1.45M	(m)	(m)	(m)	(m)	-$1.31M*	(m)	$101.12K	(m)	$286.50K
2011-03-31	Reported	(m)	-$901.95K	(m)	(m)	(m)	(m)	-$1.16M	(m)	$105.59K	(m)	(m)
2010-09-30	Reported	(m)	-$878.82K	(m)	(m)	(m)	(m)	-$1.37M*	(m)	$36.17K	(m)	(m)
2010-06-30	Reported	(m)	-$338.62K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$104.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$1.19M	(m)	(m)	(m)	-0.53%	$3.75M	$812.00K	$57.85M	$32.88M	(m)	$0.00
2024-12-31	Reported	$3.18M	(m)	(m)	(m)	1.70%	$3.10M	$4.54M	$45.36M	$27.77M	(m)	$0.00
2023-12-31	Reported	-$17.24M	(m)	(m)	(m)	-10.84%	$13.87M	-$5.72M	$37.14M	$27.34M	(m)	$0.00
2022-12-31	Reported	-$26.88M	(m)	(m)	(m)	-19.40%	$20.08M	-$16.07M	$29.77M	$25.63M	(m)	$0.00
2021-12-31	Reported	-$22.67M	(m)	(m)	(m)	-17.80%	$27.81M	-$13.40M	$22.93M	$24.18M	(m)	$0.00
2020-12-31	Reported	-$21.65M	(m)	(m)	(m)	-19.28%	$21.91M	-$9.63M	$21.58M	$17.85M	(m)	$0.00
2019-12-31	Reported	(m)	-$31.41M	(m)	(m)	(m)	$4.66M	-$19.87M	$17.35M	$17.51M	(m)	$0.00
2018-12-31	Reported	(m)	-$20.50M	(m)	(m)	(m)	$6.28M	-$17.86M	$12.92M	$11.77M	(m)	$0.00
2017-12-31	Reported	(m)	-$7.95M	(m)	(m)	(m)	$1.10M	-$9.24M	$9.31M	$6.70M	(m)	$0.00
2016-12-31	Reported	(m)	-$8.13M	(m)	(m)	(m)	$931.00K	-$11.24M	$6.47M	$4.21M	(m)	$0.00
2015-12-31	Reported	(m)	-$9.27M	(m)	(m)	(m)	$408.78K	-$13.05M	(m)	$3.24M	(m)	$0.00
2014-12-31	Reported	-$9.65M	(m)	(m)	(m)	-57.36%	$542.04K	(m)	(m)	$3.03M	(m)	$0.00
2013-12-31	Reported	-$9.51M	(m)	(m)	(m)	-86.90%	$178.78K	(m)	(m)	$2.13M	(m)	$0.00
2012-12-31	Reported	-$7.61M	(m)	(m)	(m)	-98.99%	$48.46K	-$8.66M	(m)	$1.43M	(m)	-$738.19K
2011-12-31	Reported	-$6.7M	(m)	(m)	(m)	-138.06%	$20.61K	-$7.08M	(m)	$697.36K	(m)	(m)
2010-12-31	Reported	(m)	-$4.48M	(m)	(m)	(m)	(m)	-$3.94M	(m)	$436.01K	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BIOLIFE SOLUTIONS INC (BLFS)	United States	$1.887B	23.80
TransMedics Group, Inc. (TMDX)	United States	$2.911B	15.17
CONMED Corp (CNMD)	United States	$1.353B	26.72
Ceribell, Inc. (CBLL)	United States	$0.916B	-11.27
LivaNova PLC (LIVN)		$4.158B	24.01
Integer Holdings Corp (ITGR)	United States	$4.289B	25.17
CapsoVision, Inc (CV)	United States	$0.310B	-12.68
Electromed, Inc. (ELMD)	United States	$0.233B	31.13
EDAP TMS SA (FOCL)		$0.171B
Stereotaxis, Inc. (STXS)	United States	$0.130B	-7.53